8 results
8-K
EX-4.2
BTAX
Biostax Corp.
22 Jul 22
Immune Therapeutics, Inc. Appoints Dr. Stephen Wilson as Chief Executive Officer
3:44pm
8-K
EX-4.1
BTAX
Biostax Corp.
22 Jul 22
Immune Therapeutics, Inc. Appoints Dr. Stephen Wilson as Chief Executive Officer
3:44pm
8-K
EX-4.3
BTAX
Biostax Corp.
22 Jul 22
Immune Therapeutics, Inc. Appoints Dr. Stephen Wilson as Chief Executive Officer
3:44pm
S-1/A
EX-4.1
BTAX
Biostax Corp.
IPO registration (amended)
1 Dec 16
12:00am
S-1/A
EX-4.1
BTAX
Biostax Corp.
10 Nov 16
IPO registration (amended)
12:00am
S-1
EX-4.1
g25l4u 9fba
14 Oct 16
IPO registration
12:00am
DRS/A
EX-4.1
qhhqk z210bh8r9ag
14 Oct 16
Draft registration statement (amended)
12:00am
DRS/A
EX-4.1
k486 1d17yifglp
25 Aug 16
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next